The first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease has been published. The document was developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). The Focused Update was also presented at the recent ESC Congress held in Barcelona.
“Dual antiplatelet therapy (DAPT) is a controversial topic on which a lot of conflicting evidence has been generated,” said Dr Marco Valgimigli (Switzerland), Task Force Chairperson. “This has led to a great deal of uncertainty in the medical community, particularly regarding the optimal duration of DAPT after coronary stenting.” (3)
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
